Clinical Trial Detail

NCT ID NCT00980460
Title Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

hepatoblastoma

Therapies

Irinotecan + Temsirolimus + Vincristine Sulfate

Cisplatin + Fluorouracil + Vincristine Sulfate

Doxorubicin

Age Groups: child

No variant requirements are available.